Portside Wealth Group’s ResMed RMD Stock Holding History

Portside Wealth Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,457	Closed	-$326K	–	473
2025 Q1	$326K	Buy	1,457 +54	+4%	+$12.6K	0.05%	311
2024 Q4	$321K	Sell	1,403 -55	-4%	-$13.2K	0.05%	314
2024 Q3	$356K	Sell	1,458 -156	-10%	-$34.9K	0.06%	271
2024 Q2	$309K	Sell	1,614 -22	-1%	-$4.46K	0.06%	272
2024 Q1	$324K	Buy	1,636 +80	+5%	+$14.7K	0.06%	263
2023 Q4	$268K	Buy	1,556 +126	+9%	+$19.4K	0.05%	285
2023 Q3	$212K	Sell	1,430 -41	-3%	-$7.41K	0.04%	311
2023 Q2	$321K	Buy	+1,471	New	+$328K	0.06%	247

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Portside Wealth Group's RMD Position: Q2 2025 in Review

Portside Wealth Group sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,457 shares — an estimated $326K sold.

Portside Wealth Group first reported a position in RMD in Q2 2023 and held it in 8 quarters. The position peaked at $356K in Q3 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Portside Wealth Group reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Portside Wealth Group sold 1,457 ResMed shares in Q2 2025, an estimated $326K.
Portside Wealth Group first reported a position in ResMed in Q2 2023 and held it in 8 quarters.
Portside Wealth Group's ResMed position peaked at $356K in Q3 2024.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Portside Wealth Group's 13F filing for Q2 2025, filed 11 Aug 2025.